Lorena Incorvaia et al <br/><br/>
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works